Xcout IntelSign inSubscribe

FUSION ANTIBODIES PLC

FABBiotechBelfast, United Kingdom

Fusion Antibodies plc operates as a contract research organization (CRO), providing specialized services in the research, development, and manufacturing of recombinant proteins and antibodies. The company primarily focuses on solutions for oncology and infectious diseases, serving a global clientele across the United Kingdom, broader Europe, and North America. Its comprehensive suite of offerings encompasses monoclonal antibody discovery and advancement, antibody sequencing and engineering, and a distinct platform for antibody humanization and rational affinity maturation. Additionally, Fusion Antibodies provides recombinant protein expression, stable cell line development, and cGMP-compliant scale-up services. Clients span the pharmaceutical, biotechnology, and diagnostic sectors. Notably, the company maintains a collaborative partnership with Celonic AG. Established in 2000, Fusion Antibodies plc is headquartered in Belfast, United Kingdom.

Subscribe to see FUSION ANTIBODIES PLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

FUSION ANTIBODIES PLC at a glance

FUSION ANTIBODIES PLC is a biotech company headquartered in Belfast, United Kingdom, founded in 2000. It is publicly listed (FAB) with a market capitalisation of $17.8M. Xcout tracks 7 named people at FUSION ANTIBODIES PLC, including Robert F Stoico (Director).

Industry
Biotech
Headquarters
Belfast, United Kingdom
Market cap
$17.8M
Employees
24
Ticker
FAB
Founded
2000

FUSION ANTIBODIES PLC leadership

  • Robert F StoicoDirector
  • Adrian KinkaidBoard Member, PhD
  • Colin WalshBoard Member
  • Douglas SimonBoard Member
  • Matthew BakerBoard Member, PhD
  • Richard BuickBoard Member, PhD

1 more named person on record for FUSION ANTIBODIES PLC, with roles, board committees and tenure — see the full roster →

FUSION ANTIBODIES PLC competitors

A few of FUSION ANTIBODIES PLC's closest competitors — see the full list of competitors and alternatives →

トランスジェニックグループ2342 · BiotechFukuoka City, Japan
65% matchPublic

Trans Genic Inc., a Japanese enterprise, specializes in the development, distribution, and licensing of genetically engineered animals and antibodies. Its operations are structured into two primary divisions: Drug Discovery Support Business and Investment Business. Within its Drug Discovery Support segment, the company offers a comprehensive array of services. These include the synthesis and analytical assessment of glycans (or sugar chains), alongside extensive non-clinical investigations crucial for pharmaceuticals, food products, cosmetics, and various chemical compounds. The firm conducts diverse safety evaluations for both food and pharmaceutical agents, and provides vital support for bioequivalence studies, encompassing clinical trials, pharmacokinetic measurements, and the compilation of clinical trial reports. Hospital support services are also part of its offerings. Furthermore, Trans Genic performs drug efficacy and pharmacological testing, provides strategic advisory services covering mergers & acquisitions, business restructuring, and succession planning, and undertakes contract manufacturing of items such as genetically engineered mice, antibodies, protein hypers, and expression cells. It also markets mouse models, associated products, and research reagents. Established in 1998, the company was initially known as Kumamoto Immunochemical Laboratories Inc. before rebranding as Trans Genic Inc. in April 2000. Its corporate headquarters are located in Fukuoka City, Japan.

Market cap$26.8M
Employees227
トランスジェニックグループ competitors & alternatives →

Get FUSION ANTIBODIES PLC's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Something wrong or missing about FUSION ANTIBODIES PLC? Suggest a correction

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

FUSION ANTIBODIES PLC — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on FUSION ANTIBODIES PLC in Xcout Intel

  • 7 named people with titles, LinkedIn and board committees
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →